Vitronectin–Avb3 Integrin Engagement Directs Hypoxia- Resistant Mtor Activity and Sustained Protein Synthesis Linked to Invasion by Breast Cancer Cells
Total Page:16
File Type:pdf, Size:1020Kb
Published OnlineFirst May 30, 2013; DOI: 10.1158/0008-5472.CAN-13-0218 Cancer Tumor and Stem Cell Biology Research Vitronectin–avb3 Integrin Engagement Directs Hypoxia- Resistant mTOR Activity and Sustained Protein Synthesis Linked to Invasion by Breast Cancer Cells Carolina Pola1, Silvia C. Formenti2,3, and Robert J. Schneider1,2,3 Abstract The tumor microenvironment is a crucial player in the ability of cancer cells to acquire the ability to survive under the hypoxic environment and promote migration and invasion. Translational regulation is an essential part of cancer development and progression. Protein synthesis consumes considerable cellular metabolic energy and is therefore highly regulated, in turn controlling tumor cell proliferation and survival in extreme tumor–host conditions. Protein synthesis is typically downregulated by hypoxia, impairing cell proliferation and migration. Here, we show that breast cancer cells expressing integrin avb3, when engaging the extracellular matrix (ECM) protein vitronectin, strongly upregulate both mTOR activity and cap- dependent mRNA translation, which overrides their inhibition by hypoxia and facilitates tumor cell invasion. Interaction of vitronectin with integrin avb3 results in the continued activation of the kinase mTOR despite hypoxia through a mechanism that is dependent on integrin-linked kinase but is independent of focal adhesion kinase. Continuous activation of mTOR despite hypoxia involves release of translation initiation factor eIF4E from its repressor protein 4E-BP1, which is required for vitronectin-mediated tumor cell invasion. As integrin avb3 is associated with breast cancer cell invasion and metastasis to bone, we propose that the interaction with specific ECM proteins can influence cancer cell invasion, in part, by hyperactivation of mTOR, thereby promoting and sustaining protein synthesis under hypoxic conditions. Cancer Res; 73(14); 1–8. Ó2013 AACR. Introduction mRNA translation is a checkpoint that is blocked in response to Tumor cells and their microenvironment maintain a dynam- certain physiologic stresses, including low levels of oxygen ic interaction, exchanging growth factors and cytokines and during hypoxia (6). eIF4F consists of the cap-binding protein transforming a local extracellular matrix (ECM) into an acti- eIF4E, scaffold protein eIF4G, and the ATP-dependent RNA vated stroma (1, 2). The active host microenvironment can helicase, eIF4A (7). Assembly of eIF4F is controlled by the modify gene expression programs in the tumor cell and trigger availability of eIF4E through regulation by the 4E-binding signaling pathways that control cancer cell proliferation, proteins (4E-BP). Hyperphosphorylation of 4E-BP1 by the migration and invasion (3). Components of the tumor stroma mTOR kinase complex 1 (mTORC1) maintains the inactive include a highly structured and tissue-specific ECM, stromal state of 4E-BP1, so that it cannot bind eIF4E (8). Hypoxia cells, infiltrating inflammatory cells, activated fibroblasts, and downregulates mTORC1, activating (dephosphorylating) 4E- endothelial cells (4, 5). BP1, in turn sequestering eIF4E and downregulating cap- Protein synthesis is highly regulated at the initiation phase dependent mRNA translation (6, 9). Both the noncellular – and involves recruitment of ribosomes with the eukaryotic structural components of the ECM (10 12) and hypoxia (6) initiation factor 4F (eIF4F), a complex of proteins, to the m7 can regulate protein synthesis, but their interaction has never GTP capped structure at the 50-end of mRNAs. Initiation of been extensively investigated. We therefore asked whether external signals in the breast ECM play a role in uncoupling breast cancer cell mTOR inhibition during hypoxia to sustain Authors' Affiliations: Department of 1Microbiology and 2Radiation Oncol- protein synthesis, a requirement for cancer cell invasion and ogy, and 3NYU Cancer Institute, New York University School of Medicine, New York, New York disease progression (8). To date, ECM regulators of mRNA translation include Note: Supplementary data for this article are available at Cancer Research fi Online (http://cancerres.aacrjournals.org/). bronectin (10, 11) and integrin receptors, several of which are overexpressed on breast cancers and mediate cell–ECM Corresponding Author: Robert J. Schneider, NYU School of Medicine, Alexandria Center for Life Sciences, 450 East 29th Street, New York, NY interactions (13). The regulatory effect of different integrins 10016. Phone: 212-263-6006; Fax: 646-501-4541; E-mail: on protein synthesis has also not been extensively studied. In [email protected] breast tumors, malignant progression and bone metastasis doi: 10.1158/0008-5472.CAN-13-0218 are strongly associated with the expression of integrin avb3 Ó2013 American Association for Cancer Research. (13–15). www.aacrjournals.org OF1 Downloaded from cancerres.aacrjournals.org on September 30, 2021. © 2013 American Association for Cancer Research. Published OnlineFirst May 30, 2013; DOI: 10.1158/0008-5472.CAN-13-0218 Pola et al. In this study, we show that vitronectin engagement of minutes in Dulbecco's Modified Eagle's Media (DMEM). After integrin avb3, typically present on breast cancer cells meta- incubation, cells were added to dishes coated with either 25 static to bone, hyperactivates mTOR, even during hypoxia, mg/mL collagen IV native or denatured, 10 mg/mL laminin 1, or thereby overriding the downregulation of cap-dependent 2.5 mg/mL vitronectin. Cells were allowed to attach for 12 to 16 mRNA translation. Vitronectin is an ECM component localized hours. Plating efficiency was determined as the ratio of plated primarily in the stroma and is generally only abundantly in cells to adhered cells at 12 to 16 hours using the MTT assay for contact with tumor cells after breach of the basement mem- cell number. brane during cancer cell invasion (3, 16). We show that stimulation of breast cancer cell mTOR by integrin avb3- SDS-PAGE, immunoblot analysis vitronectin interaction is linked to strongly increased tumor Cells were washed with ice-cold 1 PBS and lysed in 0.5% cell invasion during hypoxia, through a mechanism that lysis buffer [50 mmol/L HEPES, pH 7.0, 150 mmol/L NaCl, 2 involves integrin-linked kinase (ILK) but not focal adhesion mmol/L EDTA, 0.5% NP-40, 25 mmol/L NaF, 2 mmol/L sodium kinase (FAK), and mTOR activation of eIF4E-dependent mRNA orthovanadate, 25 mmol/L glycerophosphate, protease inhib- translation. Thus, integrin-mediated stimulation of protein itor (Roche)], clarified by centrifugation at 4C for 15 minutes synthesis directed by specific ECM components plays an at 13,000 rpm, protein concentration determined, solubilized important role in promoting hypoxia resistance and tumor and SDS-PAGE carried out, and protein immunoblotting con- cell invasion. ducted. Immunoblotting and protein detection by chemilumi- nescence were carried out (Amersham). Material and Methods Cell lines, cell culture, plasmids, and antibodies Protein synthesis m 35 Mouse monoclonal anti-eIF4A antibody was provided by W. Cells were labeled with 50 Ci of [ S]-methionine per mL Merrick (Case Western Reserve University, Cleveland, OH). (Easytag Express Protein Labeling Mix, Dupont/NEN) in Other antibodies were from commercial sources and included DMEM without cold methionine for 1 hour, washed twice  fi rabbit polyclonal antibodies to eIF4E, eIF4G, 4E-BP1-P (Thr 37/ with ice-chilled 1 PBS, lysed, and clari ed as above and fi 46), p70S6K, p70S6K-P (Thr 389), S6rp, S6rp-P (Ser 235/236), speci c activity determined by trichloroacetic acid (TCA) fi AMPKa-P (Thr 172), FAK, FAK-P (Tyr 576/577), mTOR, mTOR- precipitation onto GF/C lters and liquid scintillation count- P (Ser 2448), Akt and Akt-P (Ser 473), ILK, eIF2a and a-P (Ser ing. In hypoxic cells, labeling was conducted using pre-equil- 51; Cell Signaling Technology); integrin b3 (BD Biosciences ibrated media within the hypoxic chamber. Pharmingen), horseradish peroxidase (HRP)-conjugated don- key anti-rabbit or sheep anti-mouse secondary antibodies Lentivirus short hairpin RNA expression vectors (Amersham). Breast cancer cell lines MDA-MB-435, HTB-20, Short hairpin RNAs (shRNA) and scrambled nonsilencing MCF10A, and MDA-MB-231 were obtained from the American (NS) shRNAs were delivered by transduction of cells with lentivirus shRNA expression vectors. Double-stranded shRNAs Type Culture Collection. Cell lines were subjected to IMPACT 0 testing, used within 6 months for this study and grown as for cloning into lentivirus vectors were directed to the 3 - recommended. Human plasma collagen IV, laminin 1 (from untranslated region of mRNAs. Viruses were produced and basement membrane of Engelbreth-Holm-Swarm mouse sar- cells infected/selected with polybrene (4 mg/mL) and puro- m coma), and vitronectin from human plasma were from Sigma. mycin at 0.8 g/mL for 48 hours. MAb 1976/LM609 (anti-human integrin avb3) was from Che- micon International. Transfection of plasmid DNA was carried MTT proliferation assay m Ninety-six–well plates coated with vitronectin (2.5 mg/mL) out using standard conditions (Fugene) with 1 to 2 g of DNA. Transfection of siRNA to eIF4E was carried out on cells at 50% at 37 C for 1 hour were blocked with 1% bovine serum albumin  3 confluency using 5.6 mLof20mmol/L siRNA per 5  10 cells by (BSA) in PBS. MB-435 cells (2 10 per well) were plated in Oligofectamine (Invitrogen), according to manufacturer's triplicate in 1% serum in DMEM and time-lapse analyzed for 7 instructions, in the absence of serum and antibiotics. Normal days. MTT dye (Sigma) was added to wells and incubated for 4 growth media was replaced after 4 to 6 hours. siRNA to hours, cells were solubilized with MTT stripping buffer (10% eIF4E (Ambion): AAGCAAACCUGCGGCUGAUCU. Nonsilen- SDS, 45% isopropanol, 0.04 N HCl) per well, and optical density cing RNA was purchased from Ambion. determined at 570 nm. Hypoxia treatments Cell invasion assay Hypoxia experiments were carried out using a BioSphere Filter undersides of Transwells were coated with vitronectin hypoxia incubator at 0.5% O2, 95% N2,5%CO2 with growing (2.5 mg/mL) at 37 C for 1 hour, plates blocked as above and cells subjected to hypoxia for 24 hours unless otherwise noted.